Furthermore, lipid metabolism is rewired in cancer, for instance, by upregulating fatty acid synthase (FASN), the major enzyme regulating fatty acid metabolism, which is now considered a novel target for cancer patients [114, 115, 116] (Fig. 3). The gene discussed is FASN; the disease is cancer.